Indatraline
| Clinical data | |
|---|---|
| Other names | Lu 19-005 |
| Routes of administration | By mouth |
| Drug class | Serotonin-norepinephrine-dopamine reuptake inhibitor; Antidepressant |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H15Cl2N |
| Molar mass | 292.20 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Indatraline (Lu 19-005) is an antidepressive agent and non-selective monoamine transporter inhibitor that blocks the reuptake of dopamine, norepinephrine, and serotonin with similar efficacy to cocaine. This compound may be used to treat cocaine addictions as its effects have a slower onset and a longer duration than those of cocaine. Indatraline has been shown to block the action of methamphetamine and MDMA in laboratory experiments.
Category:
- Drugs not assigned an ATC code